Status:
COMPLETED
Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Kidney Transplant Recipients -ChronoVAX
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Vaccination; Infection
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Immune response to influenza vaccine in kidney transplant patients
Detailed Description
Seasonal influenza vaccination is recommended for kidney transplant patients, as influenza is responsible for significant morbidity and mortality in this immunocompromised population. Nevertheless, in...
Eligibility Criteria
Inclusion
- Renal transplant patient;
- Follow-up at Nice University Hospital;
- Age \> 18 years;
- Indication for influenza vaccination
- Free and informed consent;
- Immunosuppressive treatment including anti-calcineurin and/or Mycophenolate Mofetil (with or without corticoids).
Exclusion
- Known hypersensitivity to influenza vaccine or egg proteins;
- Influenza vaccination for the 2023-2024 season already performed;
- Current infection;
- Current acute medical condition;
- Treatment of rejection within the previous 3 months;
- Immunosuppressive therapy including CTLA4 agonist, mTOR inhibitor, complement inhibitor, anti-CD19;
- Polyvalent immunoglobulin infusion within the preceding 3 months;
- Vulnerable persons (minors, adults under guardianship or trusteeship, pregnant women, persons deprived of their liberty, persons unable to speak French);
- Subjects not affiliated to the Social Security system.
Key Trial Info
Start Date :
October 26 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 19 2024
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT06088563
Start Date
October 26 2023
End Date
June 19 2024
Last Update
November 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Nice - Hôpital Pasteur 2
Nice, Alpes-Maritimes, France, 06000